To test or "NOD-2" test: What are the questions?: The balanced viewpoint

Inflammatory Bowel Diseases

Volumn 11, Issue 5, 2005, Pages 510-512

  Rubin, David T ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ARTICLE; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENTERITIS; GENETIC COUNSELING; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MARKER GENE; MEDICAL PRACTICE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT PLANNING;

CROHN DISEASE; GENETIC SCREENING; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEEDS ASSESSMENT; NOD2 SIGNALING ADAPTOR PROTEIN; PATIENT ACCEPTANCE OF HEALTH CARE; PROGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 18944381555     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MIB.0000160738.38237.7d     Document Type: Article

References (10)

1. Brant SR, McGovern DPB. NOD2, not yet. Inflamm Bowel Dis. 2005; 11:000-000.
2. Silverberg MS. The time has come for CARD15/NOD2 testing for Crohn's disease families. Inflamm Bowel Dis. 2005;11:000-000.
3. Brant SR, Picco MF, Achkar JP, et al. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis. 2003;9:281-289.
4. Kugathasan S, Collins N, Maresso K, et al. CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn's disease. Clin Gastroenterol Hepatol. 2004;2:1003-1009.
5. Siegler M. Ethical consequences of genetic prediction. Primum non cocere Today, 1994.
6. Konda V, Huo D, Hermes G, et al. Do inflammatory bowel disease patients want genetic testing? Gastroenterology. 2003;125:A369.
7. Appleton JI, Mascarenhas J, Esplen MJ, et al. Demand for genetic testing for inflammatory bowel disease. Gastroenterology. 2004;126:A352,
8. Kessler S, Field T, Worth L, et al. Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet. 1987;26: 259-270.
9. Babul R, Adam S, Kremer B, et al. Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease. JAMA. 1993;270:2321-2325.
10. Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med. 1997;336:823-827,